Loxo Oncology Limited
- Company number
- 10572522
- Status
- Dissolved
- Type
- Private Limited Company
- Incorporated
- 19 Jan 2017
- Dissolved
- 1 Sep 2026
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BILENKER, Joshua | Director | 19 Jan 2017 | 1 Mar 2021 |
| VAN NAARDEN, Jacob | Director | 1 Mar 2021 | 28 Jan 2026 |
| BEJA, Elizabeth | Director | 1 Mar 2021 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Loxo Oncology, Inc. | Ownership Of Shares 75 To 100 Percent | 19 Jan 2017 | 15 Feb 2019 |
| Eli Lilly And Company | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
15 Feb 2019 |
Accounts
Connections
Companies at the same address
- Equinix (Ma5) Limited (12368182)
- Equinix (Services) Limited (03998776)
- Equinix (UK) Enterprises Limited (08858899)
- Equinix (UK) Limited (03672650)
- Equinix Hyperscale 1 (Ld11) Enterprises Limited (13404234)
- Equinix Hyperscale 1 (Ld11) Limited (11742432)
- Equinix Hyperscale 1 (Ld13) Limited (11863940)
- Equinix Hyperscale 1 (UK) Financing Limited (12037320)
- Equinix Hyperscale 2 (Ldx) Limited (13421063)
- FG Structures Limited (04154095)